Literature DB >> 26890174

Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013.

Christopher M Jones1, Peter G Lurie1, Wilson M Compton1.   

Abstract

Distribution of naloxone, traditionally through community-based naloxone programs, is a component of a comprehensive strategy to address the epidemic of prescription opioid and heroin overdose deaths in the United States. Recently, there has been increased focus on naloxone prescription in the outpatient setting, particularly through retail pharmacies, yet data on this practice are sparse. We found an 1170% increase in naloxone dispensing from US retail pharmacies between the fourth quarter of 2013 and the second quarter of 2015. These findings suggest that prescribing naloxone in the outpatient setting complements traditional community-based naloxone programs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26890174      PMCID: PMC4816011          DOI: 10.2105/AJPH.2016.303062

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012.

Authors:  Benjamin Levy; Leonard Paulozzi; Karin A Mack; Christopher M Jones
Journal:  Am J Prev Med       Date:  2015-04-18       Impact factor: 5.043

2.  Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Authors:  Ingrid A Binswanger; Stephen Koester; Shane R Mueller; Edward M Gardner; Kristin Goddard; Jason M Glanz
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

3.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06

4.  Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.

Authors:  Eliza Wheeler; T Stephen Jones; Michael K Gilbert; Peter J Davidson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-19       Impact factor: 17.586

5.  Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.

Authors:  Alexander Y Walley; Ziming Xuan; H Holly Hackman; Emily Quinn; Maya Doe-Simkins; Amy Sorensen-Alawad; Sarah Ruiz; Al Ozonoff
Journal:  BMJ       Date:  2013-01-30
  5 in total
  22 in total

1.  Use of online opioid overdose prevention training for first-year medical students: A comparative analysis of online versus in-person training.

Authors:  Noah Berland; Daniel Lugassy; Aaron Fox; Keith Goldfeld; So-Young Oh; Babak Tofighi; Kathleen Hanley
Journal:  Subst Abus       Date:  2019-02-15       Impact factor: 3.716

2.  The changing landscape of naloxone availability in the United States, 2011 - 2017.

Authors:  Patricia R Freeman; Emily R Hankosky; Michelle R Lofwall; Jeffery C Talbert
Journal:  Drug Alcohol Depend       Date:  2018-08-30       Impact factor: 4.492

3.  Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.

Authors:  Rachel L Graves; Elena Andreyeva; Jeanmarie Perrone; Frances S Shofer; Raina M Merchant; Zachary F Meisel
Journal:  J Addict Med       Date:  2019 Jul/Aug       Impact factor: 3.702

4.  The Importance of Learning Health Systems in Addressing the Opioid Crisis.

Authors:  Wilson M Compton; Tisha Wiley; Carlos Blanco
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

5.  Association between state Medicaid expansion status and naloxone prescription dispensing.

Authors:  Minji Sohn; Jeffery C Talbert; Chris Delcher; Emily R Hankosky; Michelle R Lofwall; Patricia R Freeman
Journal:  Health Serv Res       Date:  2020-02-07       Impact factor: 3.402

6.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

7.  Promising roles for pharmacists in addressing the U.S. opioid crisis.

Authors:  Wilson M Compton; Christopher M Jones; Jack B Stein; Eric M Wargo
Journal:  Res Social Adm Pharm       Date:  2017-12-31

8.  An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations.

Authors:  Rosanna Smart; Caroline K Geiger; Christopher M Jones; Bradley D Stein
Journal:  J Gen Intern Med       Date:  2019-10-21       Impact factor: 5.128

9.  Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Authors:  Nadia Fairbairn; Phillip O Coffin; Alexander Y Walley
Journal:  Int J Drug Policy       Date:  2017-07-04

10.  Community pharmacies as access points for addiction treatment.

Authors:  Kevin A Look; Mercedes Kile; Katie Morgan; Andrew Roberts
Journal:  Res Social Adm Pharm       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.